Evidence map›Paper›PMID 41783656›Full record

ArticleJournal of asthma and allergy2026

The Effect of Vitamin D Levels on Asthma Exacerbation in Asthmatic Patients in a Tertiary Hospital: Retrospective Study.

Alaa A Alhubaishi, Nora K Almutairi, Reem A Alghamdi, Maha A AlMolaiki, Nada A Alsaleh, Lina I Alnajjar, Sumaiah J Alarfaj, Hamdan Al-Jahdali

Abstract read
In one paragraph

Article in Journal of asthma and allergy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alaa A AlhubaishiDepartment of Pharmacy Practice, College of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.ORCID 0000-0002-4959-9865
Nora K AlmutairiDepartment of Pharmacy Practice, College of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.
Reem A AlghamdiDepartment of Pharmacy Practice, College of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.
Maha A AlMolaikiPharmaceutical Care Services, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
Nada A AlsalehDepartment of Pharmacy Practice, College of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.
Lina I AlnajjarDepartment of Pharmacy Practice, College of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.ORCID 0000-0002-6751-6488
Sumaiah J AlarfajDepartment of Pharmacy Practice, College of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.ORCID 0000-0002-3144-8305
Hamdan Al-JahdaliKing Abdullah International Medical Research Center, Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Asthma is a major global health issue, affecting over 260 million individuals and causing more than 450,000 deaths annually. A growing body of international and local research has investigated the link between Vitamin D levels and asthma outcomes. These studies suggest that Vitamin D may play a role in modulating immune responses, potentially influencing asthma control, the frequency of exacerbations, hospital visits, and overall disease severity. However, evidence remains contradictory, where other studies did not establish a direct link between vitamin D levels and asthma development given the limited real-world data from Saudi Arabia. Objective: This study aims to investigate the effect of serum Vitamin D levels and asthma exacerbations among adults, adolescents, and children within a Saudi population. Methods: A single-center retrospective cohort study was conducted at the National Guard Hospital in Riyadh, Saudi Arabia, involving 379 asthma patients with documented Vitamin D deficiency within the past 6 to 12 months. The primary outcome was the effect of serum Vitamin D levels and asthma exacerbations. The secondary outcome is defining the correlation between Vitamin D levels and asthma severity. Results: A significant difference in asthma exacerbation frequency was observed between the Vitamin D-deficient and adequate groups during both the 6- and 12-month periods, with the adequate group experiencing more frequent exacerbations (p = 0.030). Furthermore, significant associations were found between Vitamin D levels and emergency room visits (p < 0.001), as well as the need for rescue medication (p = 0.004). Conclusion: Interestingly, the results revealed that individuals with adequate vitamin D had a significantly higher frequency of exacerbations compared to those in the deficient group. These findings could be due to several confounding factors. Although vitamin D may contribute to overall respiratory health, its impact on severe asthma events may be overshadowed by other critical factors, such as Age and BMI, comorbidities, adherence to controller medications, and exposure to environmental triggers.

Indexed as

asthmaasthma exacerbationasthma severityvitamin D deficiency

Identifiers

PMID41783656
PMCPMC12956051

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.